MITD1
MIT domain-containing protein 1
Also known as: LOC129531, MITD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WV92
- Gene
- MITD1
- Ensembl
- ENSG00000158411
- Chromosome
- 2
- Canonical length
- 249 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Abscission, the separation of daughter cells at the end of cytokinesis, is effected by endosomal sorting complexes required for transport III (ESCRT-III). The protein encoded by this gene functions as a homodimer, with the N-termini binding to a subset of ESCRT-III subunits and the C-termini binding to membranes. The encoded protein regulates ESCRT-III activity and is required for proper cytokinesis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
249 residues, UniProt reviewed canonical sequence.
>Q8WV92|MITD1
1 MAKSGLRQDP QSTAAATVLK RAVELDSESR YPQALVCYQE GIDLLLQVLK GTKDNTKRCN
61 LREKISKYMD RAENIKKYLD QEKEDGKYHK QIKIEENATG FSYESLFREY LNETVTEVWI
121 EDPYIRHTHQ LYNFLRFCEM LIKRPCKVKT IHLLTSLDEG IEQVQQSRGL QEIEESLRSH
181 GVLLEVQYSS SIHDREIRFN NGWMIKIGRG LDYFKKPQSR FSLGYCDFDL RPCHETTVDI
241 FHKKHTKNILocalizationUniProt · AlphaFold · HPA
Whether an antibody against MITD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 34 nTPM
- tonsil: 27 nTPM
- thymus: 25 nTPM
- appendix: 24 nTPM
- spleen: 21 nTPM
- retina: 21 nTPM
Single-cell type
- rod photoreceptor cells: 88 nCPM
- hofbauer cells: 70 nCPM
- pituitary stem cells: 66 nCPM
- esophageal basal cells: 61 nCPM
- b-cells: 59 nCPM
- cytotrophoblasts: 59 nCPM
Immune cell
- memory B-cell: 31 nTPM
- plasmacytoid DC: 30 nTPM
- naive B-cell: 29 nTPM
- neutrophil: 28 nTPM
- NK-cell: 26 nTPM
- memory CD4 T-cell: 25 nTPM
Brain region
- white matter: 9.3 nTPM
- medulla oblongata: 8.3 nTPM
- hypothalamus: 8 nTPM
- basal ganglia: 7.8 nTPM
- pons: 7.7 nTPM
- cerebral cortex: 7.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.08
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.57
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- MIT domain
- MIT domain superfamily
- MIT (microtubule interacting and transport) domain
- MITD1, C-terminal phospholipase D-like domain
- MITD1, C-terminal phospholipase D-like domain superfamily
- MITD1, N-terminal domain
- MIT domain-containing protein 1
- Phospholipase D-like domain at C-terminus of MIT
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MITD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MITD1 as an antibody target. Whether an autoantibody or antibody against MITD1 could matter depends on whether native MITD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MITD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MITD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...